- Q1 2024 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 24, 2024$91.2 (-0.93%)Earnings
- Q4 2023 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 22, 2024$89.97 (+1.62%)Earnings
- Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Biomarin Pharmaceutical Inc Earnings Call TranscriptNov 01, 2023$84.01 (+3.14%)Earnings
- Biomarin Pharmaceutical Inc at Robert W Baird Global Healthcare Conference TranscriptSep 12, 2023
- Biomarin Pharmaceutical Inc R&D Day TranscriptSep 12, 2023
- Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Biomarin Pharmaceutical Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Biomarin Pharmaceutical Inc Earnings Call TranscriptJul 31, 2023$87.93 (+0.37%)Earnings
- Biomarin Pharmaceutical Inc U.S. Food and Drug Administration Approves ROCTAVIAN Call TranscriptJun 29, 2023
- Biomarin Pharmaceutical Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 26, 2023$93 (-2.69%)Earnings
- Biomarin Pharmaceutical Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 04, 2023
- Biomarin Pharmaceutical Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Biomarin Pharmaceutical Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Q4 2022 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 27, 2023$103.24 (+1.15%)Earnings
- Biomarin Pharmaceutical Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Biomarin Pharmaceutical Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Biomarin Pharmaceutical Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Biomarin Pharmaceutical Inc Earnings Call TranscriptOct 26, 2022$92.1 (+0.69%)Earnings
- Biomarin Pharmaceutical Inc Investor Update TranscriptAug 25, 2022
- Q2 2022 Biomarin Pharmaceutical Inc Earnings Call TranscriptAug 03, 2022$88.4 (+1.97%)Earnings
- Biomarin Pharmaceutical Inc to Discuss Positive CHMP Opinion for ROCTAVIAN TranscriptJun 24, 2022
- Biomarin Pharmaceutical Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 27, 2022$80.31 (+1.29%)Earnings
- Biomarin Pharmaceutical Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 23, 2022$82.52 (-3.34%)Earnings
- Biomarin Pharmaceutical Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 18, 2022
- Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Biomarin Pharmaceutical Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Biomarin Pharmaceutical Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 02, 2021
- Biomarin Pharmaceutical Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Biomarin Pharmaceutical Inc R&D Day (Virtual) TranscriptNov 30, 2021
- Biomarin Pharmaceutical Inc to Discuss FDA Approval for VOXZOGOâ„¢ Call TranscriptNov 19, 2021
- Biomarin Pharmaceutical Inc at Stifel Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Biomarin Pharmaceutical Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Biomarin Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2021
- Biomarin Pharmaceutical Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Q3 2021 Biomarin Pharmaceutical Inc Earnings Call TranscriptOct 27, 2021$71.72 (-2.32%)Earnings
- Biomarin Pharmaceutical Inc at JPMorgan US All Stars Conference (Virtual) TranscriptSep 22, 2021
- Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Biomarin Pharmaceutical Inc Earnings Call TranscriptJul 28, 2021$78.73 (+0.51%)Earnings
- Biomarin Pharmaceutical Inc at Bank of America NAPA Healthcare Conference (Virtual) TranscriptJun 16, 2021
- Biomarin Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Biomarin Pharmaceutical Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2021
- Biomarin Pharmaceutical Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Biomarin Pharmaceutical Inc at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- Biomarin Pharmaceutical Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Biomarin Pharmaceutical Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Biomarin Pharmaceutical Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 04, 2021
- Q1 2021 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 29, 2021$80.18 (-0.35%)Earnings
- Biomarin Pharmaceutical Inc at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 29, 2021
- Biomarin Pharmaceutical Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Biomarin Pharmaceutical Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Biomarin Pharmaceutical Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 26, 2021
- Q4 2020 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 25, 2021$81.76 (-1.87%)Earnings
- Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Biomarin Pharmaceutical Inc at Goldman Sachs Healthcare CEOs Unscripted Conference (Virtual) TranscriptJan 05, 2021
- Biomarin Pharmaceutical Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 03, 2020
- Biomarin Pharmaceutical Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 02, 2020
- Biomarin Pharmaceutical Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 18, 2020
- Biomarin Pharmaceutical Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Biomarin Pharmaceutical Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Biomarin Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q3 2020 Biomarin Pharmaceutical Inc Earnings Call TranscriptNov 05, 2020$75.05 (-1.73%)Earnings
- Biomarin Pharmaceutical Inc at Morningstar Management Behind the Moat Conference (Virtual) TranscriptSep 30, 2020
- Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Biomarin Pharmaceutical Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Biomarin Pharmaceutical Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Biomarin Pharmaceutical Inc at JPMorgan US All-Stars Conference (Virtual) TranscriptSep 16, 2020
- Biomarin Pharmaceutical Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Biomarin Pharmaceutical Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 09, 2020
- Biomarin Pharmaceutical Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 13, 2020
- Biomarin Pharmaceutical Inc at Wedbush PacGrow Healthcare Virtual Conference TranscriptAug 11, 2020
- Q2 2020 Biomarin Pharmaceutical Inc Earnings Call TranscriptAug 04, 2020$119.83 (-1.81%)Earnings
- Biomarin Pharmaceutical Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 24, 2020
- Biomarin Pharmaceutical Inc to Discuss Results from the Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A Presented at the WFH Virtual Summit TranscriptJun 17, 2020
- Biomarin Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Biomarin Pharmaceutical Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- Biomarin Pharmaceutical Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Biomarin Pharmaceutical Inc at RBC Global Healthcare Conference TranscriptMay 19, 2020
- Biomarin Pharmaceutical Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 29, 2020$94.71 (+0.23%)Earnings
- Biomarin Pharmaceutical Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 26, 2020$91.22 (+0.24%)Earnings
- Biomarin Pharmaceutical Inc at Leerink Global Healthcare Conference TranscriptFeb 26, 2020
- Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Biomarin Pharmaceutical Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- Biomarin Pharmaceutical Inc at Jefferies London Healthcare Conference TranscriptNov 21, 2019
- Biomarin Pharmaceutical Inc R&D Day TranscriptNov 14, 2019
- Q3 2019 Biomarin Pharmaceutical Inc Earnings Call TranscriptOct 23, 2019$69.01 (+1.89%)Earnings
- Biomarin Pharmaceutical Inc at Jefferies Gene Therapy Summit TranscriptOct 08, 2019
- Biomarin Pharmaceutical Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Biomarin Pharmaceutical Inc Earnings Call TranscriptAug 01, 2019$81 (+2.12%)Earnings
- Biomarin Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Biomarin Pharmaceutical Inc to Discuss Valoctocogene Roxaparvovec Phase 2 and Phase 3 Update Call TranscriptMay 28, 2019
- Biomarin Pharmaceutical Inc at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- Biomarin Pharmaceutical Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Biomarin Pharmaceutical Inc Earnings Call TranscriptApr 25, 2019$85.31 (-0.21%)Earnings
- Biomarin Pharmaceutical Inc at Cowen Health Care Conference TranscriptMar 12, 2019
- Biomarin Pharmaceutical Inc at Leerink Partners Global Healthcare Conference TranscriptFeb 27, 2019
- Q4 2018 Biomarin Pharmaceutical Inc Earnings Call TranscriptFeb 21, 2019$88.81 (-2.04%)Earnings
Biomarin Pharmaceutical Inc Investor Update Transcript
Welcome to the BioMarin Conference Call to discuss European Approval of ROCTAVIAN. Hosting the conference call today from BioMarin is Traci McCarty, Head of Investor Relations. Please go ahead. Traci.
Thank you very much operator, and thank you all for joining U.S. today to talk about ROCTAVIAN approval in Europe. On the call from BioMarin's management team are J.J. Bienaime, Chairman and Chief Executive Officer; Jeff Ajer, Chief Commercial Officer; Hank Fuchs, President of Worldwide R&D; and Brian Mueller, our Chief Financial Officer.
To remind you, this non-confidential presentation contains forward-looking statements about ROCTAVIAN and the business prospects of BioMarin Pharmaceutical Inc., including expectations regarding BioMarin's financial performance and the clinical development and potential regulatory approval of ROCTAVIAN and other commercial products and products and development. Results may differ materially depending on the timing and nature of decisions by regulatory authorities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)